UB Paderborn / Katalog / Suche / in CDI

Impact of growth hormone-releasing hormone antagonist on decidual stromal cell growth and apoptosis in vitro

Biology of reproduction, 2022-01, Vol.106 (1), p.145-154

2022

Link zum Volltext

Verfügbarkeit prüfen

Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes

Proceedings of the National Academy of Sciences - PNAS, 2017-10, Vol.114 (44), p.11745-11750

2017

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction

Proceedings of the National Academy of Sciences - PNAS, 2021-01, Vol.118 (4)

2021

Link zum Volltext

Verfügbarkeit prüfen

Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation

Molecular psychiatry, 2020-02, Vol.25 (2), p.275-282

2020

Link zum Volltext

Verfügbarkeit prüfen

Do as I say, not as I do – The paradoxical relationship between actual cat keeping practices and knowledge about wildcat conservation among Hungarian cat owners

Biological conservation, 2024-05, Vol.293, Article 110586

2024

Link zum Volltext

Verfügbarkeit prüfen

Spring migration phenology of Eurasian Woodcocks tagged with GPS-Argos transmitters in Central Europe

Ornis fennica, 2022-10, Vol.99 (4), p.1-116

2022

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression

Oncotarget, 2017-01, Vol.8 (3), p.4410-4421

2017

Link zum Volltext

Verfügbarkeit prüfen

Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway

Reproductive biology and endocrinology, 2010-05, Vol.8 (1), p.54-54, Article 54

2010

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCδ-mediated activation of p53/p21

Cancer letters, 2010-12, Vol.298 (1), p.16-25

2010

Link zum Volltext

Verfügbarkeit prüfen

Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone

Pharmacological research, 2016-09, Vol.111, p.859-866

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4769: Growth hormone-releasing hormone (GHRH) antagonist attenuates cell motility of human endometrial cancer by down-regulating Twist and N-Cadherin expression

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4769-4769

2013

Link zum Volltext

Verfügbarkeit prüfen

Antitumor effects of the cytotoxic luteinizing hormone–releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

American journal of obstetrics and gynecology, 2002-09, Vol.187 (3), p.528-537

2002

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy

Journal of the American Heart Association, 2015-03, Vol.4 (4)

2015

Link zum Volltext

Verfügbarkeit prüfen

Antagonist of Growth Hormone-Releasing Hormone Induces Apoptosis in LNCaP Human Prostate Cancer Cells through a Ca2+-Dependent Pathway

Proceedings of the National Academy of Sciences - PNAS, 2005-03, Vol.102 (9), p.3435-3440

2005

Link zum Volltext

Verfügbarkeit prüfen

Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer

Journal of cancer research and clinical oncology, 2012-03, Vol.138 (3), p.387-395

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 214: Reduction of Scar Tissue after GHRH-A Treatment in a Swine Model of Sub-acute Ischemic Cardiomyopathy

Circulation research, 2014-07, Vol.115 (suppl_1)

2014

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCd-mediated activation of p53/p21

Cancer letters, 2010-12, Vol.298 (1), p.16-25

2010

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKC[delta]-mediated activation of p53/p21

Cancer letters, 2010-12, Vol.298 (1), p.16

2010

Link zum Volltext

Verfügbarkeit prüfen

P10-7-5 Role of the tumoral GHRH receptor in the cell proliferation

ENDOCRINE JOURNAL, 2010, Vol.57 (suppl.2-2), p.S590-S591

2010

Link zum Volltext

Verfügbarkeit prüfen

Immunocytochemical localization of growth hormone-releasing factor in the rat hypothalamus

Endocrinology (Philadelphia), 1984-04, Vol.114 (4), p.1082-1085

1984

Link zum Volltext

Verfügbarkeit prüfen

Treatment of experimental DMBA induced mammary carcinoma with cetrorelix (SB-75) : a potent antagonist of luteinizing hormone-releasing hormone

Journal of cancer research and clinical oncology, 1992, Vol.118 (1), p.44-49

1992

Link zum Volltext

Verfügbarkeit prüfen

Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca super(2+)-dependent pathway

Proceedings of the National Academy of Sciences - PNAS, 2005-03, Vol.102 (9), p.3435-3440

2005

Link zum Volltext

Verfügbarkeit prüfen

Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca 2+ -dependent pathway

Proceedings of the National Academy of Sciences - PNAS, 2005-03, Vol.102 (9), p.3435-3440

2005

Link zum Volltext

Verfügbarkeit prüfen

Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal d-Trp or d-Tpi

International Journal of Peptide and Protein Research, 1991-12, Vol.38 (6), p.593-600

1991

Link zum Volltext

Verfügbarkeit prüfen

Corticotropin releasing factor (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus

Neuroendocrinology, 1984-01, Vol.39 (4), p.296

1984

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Impact of growth hormone-releasing hormone antagonist on decidual stromal cell growth and apoptosis in vitro

Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes

Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction

Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation

Do as I say, not as I do – The paradoxical relationship between actual cat keeping practices and knowledge about wildcat conservation among Hungarian cat owners

Spring migration phenology of Eurasian Woodcocks tagged with GPS-Argos transmitters in Central Europe

Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression

Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway

Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCδ-mediated activation of p53/p21

Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone

Abstract 4769: Growth hormone-releasing hormone (GHRH) antagonist attenuates cell motility of human endometrial cancer by down-regulating Twist and N-Cadherin expression

Antitumor effects of the cytotoxic luteinizing hormone–releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy

Antagonist of Growth Hormone-Releasing Hormone Induces Apoptosis in LNCaP Human Prostate Cancer Cells through a Ca2+-Dependent Pathway

Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer

Abstract 214: Reduction of Scar Tissue after GHRH-A Treatment in a Swine Model of Sub-acute Ischemic Cardiomyopathy

Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCd-mediated activation of p53/p21

Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKC[delta]-mediated activation of p53/p21

P10-7-5 Role of the tumoral GHRH receptor in the cell proliferation

Immunocytochemical localization of growth hormone-releasing factor in the rat hypothalamus

Treatment of experimental DMBA induced mammary carcinoma with cetrorelix (SB-75) : a potent antagonist of luteinizing hormone-releasing hormone

Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca super(2+)-dependent pathway

Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca 2+ -dependent pathway

Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal d-Trp or d-Tpi

Corticotropin releasing factor (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus

Suchergebnisse filtern